Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
0.7202
-0.1008 (-12.28%)
At close: Nov 20, 2026, 4:00 PM EST
0.7300
+0.0098 (1.36%)
After-hours: Nov 20, 2026, 5:02 PM EST
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $4.58 million as of November 20, 2026. It is the 44,959th most valuable company in the world and the 5,902nd biggest in the United States. Its market cap has decreased by 51.58% in one year.
Market Cap
4.58M
Enterprise Value
-11.42M
1-Year Change
-51.58%
Global Rank
Country Rank
#5,902 United States
Category
ChartMarket Cap Chart
Since February 17, 2015, Kiora Pharmaceuticals's market cap has decreased from $35.73M to $4.58M, a decrease of -87.17%. That is a compound annual growth rate of -16.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 4.65M | -52.17% |
| Dec 31, 2025 | 9.71M | -30.96% |
| Dec 31, 2024 | 14.07M | 250.17% |
| Dec 29, 2023 | 4.02M | -34.81% |
| Dec 30, 2022 | 6.16M | -67.75% |
| Dec 31, 2021 | 19.11M | -29.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 5.03M |
| Cerenome | 4.93M |
| Tempest Therapeutics | 4.85M |
| SeaStar Medical Holding | 4.79M |
| Niki BioSolutions | 4.77M |
| Cardio Diagnostics Holdings | 4.74M |
| Pulmatrix | 4.71M |
| Can-Fite BioPharma | 4.60M |